TM7SF2 as a Potential Biomarker in Colorectal Cancer: Implications for Metastasis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Biomarkers

Background:

• Colorectal cancer (CRC) is a leading cause of cancer death globally.
• Metastasis significantly reduces survival rates in CRC patients.
• Early detection of metastasis-related factors is crucial for improving patient outcomes.

Purpose of the Study:

• To validate the transmembrane 7 superfamily member 2 (TM7SF2) gene as a biomarker for predicting CRC metastasis.
• To investigate the functional role of TM7SF2 in CRC cell behavior.

Main Methods:

• Immunohistochemical staining of 236 CRC tissues to analyze TM7SF2 expression.
• Kaplan-Meier survival analysis correlating TM7SF2 expression with patient survival.
• TM7SF2 knockdown using siRNAs in CRC cell lines (SW480, SW620) followed by RT-PCR and immunoblotting.
• Functional assays assessing cell proliferation, migration, invasion, and colony formation.

Main Results:

• TM7SF2 expression was significantly associated with the clinical stage of CRC.
• Overexpression of TM7SF2 correlated with decreased survival rates in CRC patients (log-rank, p < 0.001).
• TM7SF2 knockdown suppressed cell proliferation, migration, invasion, and colony formation in CRC cell lines.

Conclusions:

• TM7SF2 is a promising biomarker for predicting metastasis in colorectal cancer.
• TM7SF2 plays a significant role in promoting CRC cell proliferation and metastasis.
• Targeting TM7SF2 may offer a novel therapeutic strategy for colorectal cancer prevention.